메뉴 건너뛰기
Cancer Investigation
Volumn 14, Issue 4, 1996, Pages 361-370
The case for adjuvant radiation therapy in advanced Hodgkin's disease
Author keywords

[No Author keywords available]
Indexed keywords

COMBINATION CHEMOTHERAPY; CYTOTOXICITY; HEART DISEASE; HODGKIN DISEASE; LEUKEMIA; LOW ENERGY RADIATION; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SECOND CANCER; SOLID TUMOR;
EID: 0029889010     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609012164     Document Type: Review
Times cited : (16)
References (79)
  • 1
    • 0028136295 scopus 로고
    • Improving adjuvant therapy for rectal cancer by combined protracted infusion fluorouracil with radiation therapy after curative surgery
    • O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combined protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994.
    • (1994) N Engl J Med , vol.331 , pp. 502-507
    • O'Connell, M.J.1    Martenson, J.A.2    Wieand, H.S.3
  • 2
    • 0026726794 scopus 로고
    • Adjuvant radiation therapy for colorectal cancer
    • Cummings BJ: Adjuvant radiation therapy for colorectal cancer. Cancer 70:1372-1383, 1992.
    • (1992) Cancer , vol.70 , pp. 1372-1383
    • Cummings, B.J.1
  • 3
    • 0026632370 scopus 로고
    • Combined modality therapy of rectal cancer: Decreased acute toxicity with a preoperative approach
    • Minsky BD, Cohen AM, Kemeny N, et al: Combined modality therapy of rectal cancer: Decreased acute toxicity with a preoperative approach. J Clin Oncol 10:1218-1224, 1992.
    • (1992) J Clin Oncol , vol.10 , pp. 1218-1224
    • Minsky, B.D.1    Cohen, A.M.2    Kemeny, N.3
  • 4
    • 0027474302 scopus 로고
    • Adjuvant treatment in the curative management of rectal cancer: A critical review of the results of clinical randomized trials
    • Bosset JF, Horiot JC: Adjuvant treatment in the curative management of rectal cancer: A critical review of the results of clinical randomized trials. Eur J Cancer 29:770-774, 1993.
    • (1993) Eur J Cancer , vol.29 , pp. 770-774
    • Bosset, J.F.1    Horiot, J.C.2
  • 7
    • 0025807080 scopus 로고
    • Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
    • Department of Veterans' Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991.
    • (1991) N Engl J Med , vol.324 , pp. 1685-1690
  • 8
    • 0026769381 scopus 로고
    • Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
    • Herskovic A, Martz K, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992.
    • (1992) N Engl J Med , vol.326 , pp. 1593-1598
    • Herskovic, A.1    Martz, K.2    Al-Sarraf, M.3
  • 9
    • 0026482388 scopus 로고
    • A meta-analysis of thoracic radiotherapy for small cell lung cancer
    • Pignon J, Arriagada R, Idhe DC, et al: A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 327:1618-1624, 1992.
    • (1992) N Engl J Med , vol.327 , pp. 1618-1624
    • Pignon, J.1    Arriagada, R.2    Idhe, D.C.3
  • 10
    • 0026636032 scopus 로고
    • Multi-modality treatment of stage IIIA non-small cell lung carcinoma: A critical review of the literature and strategies for future research
    • Strauss GM, Langer MP, Elias AD, et al: Multi-modality treatment of stage IIIA non-small cell lung carcinoma: A critical review of the literature and strategies for future research. J Clin Oncol 10: 829-838, 1992.
    • (1992) J Clin Oncol , vol.10 , pp. 829-838
    • Strauss, G.M.1    Langer, M.P.2    Elias, A.D.3
  • 11
    • 0028200561 scopus 로고
    • Multi-modality therapy for non-small cell lung cancer
    • Lilenbaum RC, Green MR: Multi-modality therapy for non-small cell lung cancer. Oncology 8:25-36, 1994.
    • (1994) Oncology , vol.8 , pp. 25-36
    • Lilenbaum, R.C.1    Green, M.R.2
  • 12
    • 0024420591 scopus 로고
    • Combined modality treatment with radiotherapy and chemotherapy
    • Tannock IF: Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 16:83-101, 1989.
    • (1989) Radiother Oncol , vol.16 , pp. 83-101
    • Tannock, I.F.1
  • 13
    • 0027480871 scopus 로고
    • Interactions of chemotherapy and radiation
    • Yokes EE: Interactions of chemotherapy and radiation. Semin Oncol 20:70-79, 1993.
    • (1993) Semin Oncol , vol.20 , pp. 70-79
    • Yokes, E.E.1
  • 14
    • 0027394689 scopus 로고
    • Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
    • 13a. Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002-1006, 1993.
    • (1993) N Engl J Med , vol.328 , pp. 1002-1006
    • Fisher, R.I.1    Gaynor, E.R.2    Dahlberg, S.3
  • 15
    • 0015409893 scopus 로고
    • Theoretical considerations in combinations of localized and systemic therapy for neoplastic diseases
    • Fischer JJ, Papac RJ: Theoretical considerations in combinations of localized and systemic therapy for neoplastic diseases. J Theoret Biol 37:105-114, 1972.
    • (1972) J Theoret Biol , vol.37 , pp. 105-114
    • Fischer, J.J.1    Papac, R.J.2
  • 16
    • 0015812635 scopus 로고
    • Combination chemotherapy in advanced Hodgkin's disease: Induction and maintenance of remission
    • Frei E III, Luce JK, Gamble JF, et al: Combination chemotherapy in advanced Hodgkin's disease: Induction and maintenance of remission. Ann Intern Med 79:376-382, 1973.
    • (1973) Ann Intern Med , vol.79 , pp. 376-382
    • Frei III, E.1    Luce, J.K.2    Gamble, J.F.3
  • 17
    • 0018120974 scopus 로고
    • Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy
    • Young RC, Cannellos GP, Chabner BA, et al: Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy. Cancer 42:1001-1007, 1978.
    • (1978) Cancer , vol.42 , pp. 1001-1007
    • Young, R.C.1    Cannellos, G.P.2    Chabner, B.A.3
  • 18
    • 0026639621 scopus 로고
    • An updated dose response analysis in Hodgkin's disease
    • Vijayakumar S, Myrianthopoulos LC: An updated dose response analysis in Hodgkin's disease. Radiother Oncol 24:1-13, 1992.
    • (1992) Radiother Oncol , vol.24 , pp. 1-13
    • Vijayakumar, S.1    Myrianthopoulos, L.C.2
  • 19
    • 0013920885 scopus 로고
    • Evidence for a lumoricidal dose level in the radiotherapy of Hodgkin's disease
    • Kaplan HS: Evidence for a lumoricidal dose level in the radiotherapy of Hodgkin's disease. Cancer Res 26:1221-1224, 1966.
    • (1966) Cancer Res , vol.26 , pp. 1221-1224
    • Kaplan, H.S.1
  • 20
    • 0028353763 scopus 로고
    • A re-analysis of available dose response and time-dose data in Hodgkin's disease
    • Brincker H, Bentzen SM: A re-analysis of available dose response and time-dose data in Hodgkin's disease. Radiother Oncol 30:227-230, 1994.
    • (1994) Radiother Oncol , vol.30 , pp. 227-230
    • Brincker, H.1    Bentzen, S.M.2
  • 21
    • 0015605419 scopus 로고
    • Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease
    • Prosnitz LR, Farber LR, Fischer JJ, et al: Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease. Radiology 107:187-193, 1973.
    • (1973) Radiology , vol.107 , pp. 187-193
    • Prosnitz, L.R.1    Farber, L.R.2    Fischer, J.J.3
  • 22
    • 0026684690 scopus 로고
    • Late cardiopulmonary toxicity after treatment for Hodgkin's disease
    • Allavena C, Conroy T, Aletti P, et al: Late cardiopulmonary toxicity after treatment for Hodgkin's disease. Br J Cancer 65:908-912, 1992.
    • (1992) Br J Cancer , vol.65 , pp. 908-912
    • Allavena, C.1    Conroy, T.2    Aletti, P.3
  • 23
    • 0026062290 scopus 로고
    • Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's disease
    • Brice P, Tredaniel J, Monsuez JJ, et al: Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's disease. Ann Oncol 2:73-76, 1991.
    • (1991) Ann Oncol , vol.2 , pp. 73-76
    • Brice, P.1    Tredaniel, J.2    Monsuez, J.J.3
  • 24
    • 0026513214 scopus 로고
    • Coronary artery disease mortality in patients treated for Hodgkin's disease
    • Boivin J, Hutchison GB, Lubin JH, et al: Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 69: 1241-1247, 1992.
    • (1992) Cancer , vol.69 , pp. 1241-1247
    • Boivin, J.1    Hutchison, G.B.2    Lubin, J.H.3
  • 25
    • 0027223298 scopus 로고
    • Cardiac disease following treatment of Hodgkin's disease in children and adolescents
    • Hancock SL, Donaldson SS, Hoppe RT: Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1208-1215, 1993.
    • (1993) J Clin Oncol , vol.11 , pp. 1208-1215
    • Hancock, S.L.1    Donaldson, S.S.2    Hoppe, R.T.3
  • 26
    • 0027386156 scopus 로고
    • Factors effecting late mortality from heart disease after treatment of Hodgkin's disease
    • Hancock SL, Tucker MA, Hoppe RT: Factors effecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270:1949-1955, 1993.
    • (1993) JAMA , vol.270 , pp. 1949-1955
    • Hancock, S.L.1    Tucker, M.A.2    Hoppe, R.T.3
  • 27
    • 0024522061 scopus 로고
    • Non-malignant complications of therapy for Hodgkin's disease
    • Hohl RJ, Schilsky RL: Non-malignant complications of therapy for Hodgkin's disease. Hematol Oncol Clin North Am 3:331343, 1989.
    • (1989) Hematol Oncol Clin North Am , vol.3 , pp. 331343
    • Hohl, R.J.1    Schilsky, R.L.2
  • 28
    • 0022379945 scopus 로고
    • Late cardiac, thyroid and pulmonary sequalae of mantle radiotherapy for Hodgkin's disease
    • Morgan GW, Freeman AP, McLean RG, et al: Late cardiac, thyroid and pulmonary sequalae of mantle radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 11:1925-1931, 1985.
    • (1985) Int J Radiat Oncol Biol Phys , vol.11 , pp. 1925-1931
    • Morgan, G.W.1    Freeman, A.P.2    McLean, R.G.3
  • 29
    • 0022636033 scopus 로고
    • Hodgkin's disease: Is there a price for successful treatment?
    • Rubin P, Zagars G, Chuang C, et al: Hodgkin's disease: Is there a price for successful treatment? Int J Radiat Oncol Biol Phys 12: 153-166, 1986.
    • (1986) Int J Radiat Oncol Biol Phys , vol.12 , pp. 153-166
    • Rubin, P.1    Zagars, G.2    Chuang, C.3
  • 30
    • 0028452940 scopus 로고
    • The pulmonary effects of thoracic irradiation
    • Marks LB: The pulmonary effects of thoracic irradiation. Oncology 8:89-104, 1994.
    • (1994) Oncology , vol.8 , pp. 89-104
    • Marks, L.B.1
  • 31
    • 0023175235 scopus 로고
    • Radiation and chemotherapy induced lung toxicity
    • Van Houtte P: Radiation and chemotherapy induced lung toxicity. Int J Radiat Oncol Biol Phys 13:647-649, 1987.
    • (1987) Int J Radiat Oncol Biol Phys , vol.13 , pp. 647-649
    • Van Houtte, P.1
  • 32
    • 0025091589 scopus 로고
    • Improved survival in advanced Hodgkin's disease with the use of combined modality therapy
    • Brizel DM, Winer EP, Prosnitz LR, et al: Improved survival in advanced Hodgkin's disease with the use of combined modality therapy. Int J Radiat Oncol Biol Phys 19:535-542, 1990.
    • (1990) Int J Radiat Oncol Biol Phys , vol.19 , pp. 535-542
    • Brizel, D.M.1    Winer, E.P.2    Prosnitz, L.R.3
  • 33
    • 0029912399 scopus 로고    scopus 로고
    • The effect of ABVD chemotherapy with or without mediastinal irradiation on pulmonary function and symptoms in early stage Hodgkin's disease
    • in press
    • 31a. Hirsch A, vander Els N, Straus D, et al: The effect of ABVD chemotherapy with or without mediastinal irradiation on pulmonary function and symptoms in early stage Hodgkin's disease. J Clin Oncol, 1996. (in press).
    • (1996) J Clin Oncol
    • Hirsch, A.1    Vander Els, N.2    Straus, D.3
  • 34
    • 0023113215 scopus 로고
    • Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease
    • Blayney DW, Longo DL, Young RC, et al: Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 316:710-714, 1987.
    • (1987) N Engl J Med , vol.316 , pp. 710-714
    • Blayney, D.W.1    Longo, D.L.2    Young, R.C.3
  • 35
  • 36
    • 0025338858 scopus 로고
    • Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas
    • Lavey RS, Eby NL, Prosnitz LR: Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer 66:80-88, 1990.
    • (1990) Cancer , vol.66 , pp. 80-88
    • Lavey, R.S.1    Eby, N.L.2    Prosnitz, L.R.3
  • 37
    • 0023852174 scopus 로고
    • Second malignancies in Hodgkin's disease: The Royal Marsden Hospital experience
    • Coleman M, Easton DF, Horowich A, et al: Second malignancies in Hodgkin's disease: The Royal Marsden Hospital experience. Radiother Oncol 11:229-238, 1988.
    • (1988) Radiother Oncol , vol.11 , pp. 229-238
    • Coleman, M.1    Easton, D.F.2    Horowich, A.3
  • 38
    • 0028329713 scopus 로고
    • Leukemia risks following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with Teniposide combinations, number of episodes of chemotherapy, and bone marrow damage
    • van Leeuwen FE, Chorus AMJ, van den Belt-Dusebolt AW, et al: Leukemia risks following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with Teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 12:1063-1073, 1994.
    • (1994) J Clin Oncol , vol.12 , pp. 1063-1073
    • Van Leeuwen, F.E.1    Chorus, A.M.J.2    Van Den Belt-Dusebolt, A.W.3
  • 39
    • 0025155274 scopus 로고
    • Leukemia following treatment for Hodgkin's disease: The experience of the British National Lymphoma Investigation
    • Devereux S, Scalssie TG, Vaughan-Hudson G, et al: Leukemia following treatment for Hodgkin's disease: The experience of the British National Lymphoma Investigation. Br Med J 301:1077-1080, 1990.
    • (1990) Br Med J , vol.301 , pp. 1077-1080
    • Devereux, S.1    Scalssie, T.G.2    Vaughan-Hudson, G.3
  • 40
    • 0027403456 scopus 로고
    • Acute leukemia after the treatment of Hodgkin's disease
    • Henry-Amar M, Deitrich P: Acute leukemia after the treatment of Hodgkin's disease. Hematol Oncol Clin North Am 7:369-387, 1993.
    • (1993) Hematol Oncol Clin North Am , vol.7 , pp. 369-387
    • Henry-Amar, M.1    Deitrich, P.2
  • 41
    • 0023264243 scopus 로고
    • Risk of therapy related leukemia and preleukemia after Hodgkin's disease: Relation to age, cumulative dose of alkylating agents, and time from chemotherapy
    • Pedersen-Bjergaard J, Larsen SO, Struck J, et al: Risk of therapy related leukemia and preleukemia after Hodgkin's disease: Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 2:83-88, 1987.
    • (1987) Lancet , vol.2 , pp. 83-88
    • Pedersen-Bjergaard, J.1    Larsen, S.O.2    Struck, J.3
  • 42
    • 0022447771 scopus 로고
    • Second acute leukemia and other malignancies following treatment for Hodgkin's disease
    • Valagussa P, Santoro A, Fossati-Bellani F, et al: Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4:830-837, 1986.
    • (1986) J Clin Oncol , vol.4 , pp. 830-837
    • Valagussa, P.1    Santoro, A.2    Fossati-Bellani, F.3
  • 43
    • 0025367025 scopus 로고
    • Increased risk of secondary acute nonlymphocytic leukemia after extended field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease
    • Andrieu JM, Ifrah N, Payen C, et al: Increased risk of secondary acute nonlymphocytic leukemia after extended field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. J Clin Oncol 8:1148-1154, 1990.
    • (1990) J Clin Oncol , vol.8 , pp. 1148-1154
    • Andrieu, J.M.1    Ifrah, N.2    Payen, C.3
  • 44
    • 0022001150 scopus 로고
    • Reduction of fatal complications from combined modality therapy in Hodgkin's disease
    • Mauch PM, Cannellos GP, Rosenthal DS, et al: Reduction of fatal complications from combined modality therapy in Hodgkin's disease. J Clin Oncol 3:501-505, 1985.
    • (1985) J Clin Oncol , vol.3 , pp. 501-505
    • Mauch, P.M.1    Cannellos, G.P.2    Rosenthal, D.S.3
  • 45
    • 0027537098 scopus 로고
    • Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time and age
    • Abrahamsen JF, Andersen A, Hannisdal E, et al: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time and age. J Clin Oncol 11:255-261, 1993.
    • (1993) J Clin Oncol , vol.11 , pp. 255-261
    • Abrahamsen, J.F.1    Andersen, A.2    Hannisdal, E.3
  • 46
    • 0029021935 scopus 로고
    • Incidence of second cancers in patients treated for Hodgkin' s disease
    • Boivin J, Hutchison GB, Zaluber AG, et al: Incidence of second cancers in patients treated for Hodgkin' s disease. J Natl Cancer Inst 87:732-741, 1995.
    • (1995) J Natl Cancer Inst , vol.87 , pp. 732-741
    • Boivin, J.1    Hutchison, G.B.2    Zaluber, A.G.3
  • 47
    • 0026031879 scopus 로고
    • Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study
    • Cimino G, Papa G, Tura S, et al: Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study. J Clin Oncol 9:432-437, 1991.
    • (1991) J Clin Oncol , vol.9 , pp. 432-437
    • Cimino, G.1    Papa, G.2    Tura, S.3
  • 49
    • 0023681279 scopus 로고
    • Second malignancies after childhood Hodgkin's disease: The Memorial Sloan-Kettering Cancer Center experience
    • Kushner BH, Zalubar A, Tan CTC: Second malignancies after childhood Hodgkin's disease: The Memorial Sloan-Kettering Cancer Center experience. Cancer 62:1364-1370, 1988.
    • (1988) Cancer , vol.62 , pp. 1364-1370
    • Kushner, B.H.1    Zalubar, A.2    Tan, C.T.C.3
  • 50
    • 0026560447 scopus 로고
    • Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation
    • Swerdlow AJ, Douglas AJ, Vaughan-Hudson G, et al: Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. Br Med J 304:1137-1143, 1992.
    • (1992) Br Med J , vol.304 , pp. 1137-1143
    • Swerdlow, A.J.1    Douglas, A.J.2    Vaughan-Hudson, G.3
  • 51
    • 0027360411 scopus 로고
    • Risk of second primary cancers after Hodgkin's disease in patients in the British National Lymphoma Investigation: Relationships to host factors, histology and stage of Hodgkin's disease and splenectomy
    • Swerdlow AJ, Douglas AJ, Vaughan-Hudson G, et al: Risk of second primary cancers after Hodgkin's disease in patients in the British National Lymphoma Investigation: Relationships to host factors, histology and stage of Hodgkin's disease and splenectomy. Br J Cancer 68:1006-1011, 1993.
    • (1993) Br J Cancer , vol.68 , pp. 1006-1011
    • Swerdlow, A.J.1    Douglas, A.J.2    Vaughan-Hudson, G.3
  • 52
    • 0027394732 scopus 로고
    • Solid second cancers following Hodgkin's disease
    • Tucker MA: Solid second cancers following Hodgkin's disease. Hematol Oncol Clin North Am 7:389-400, 1993.
    • (1993) Hematol Oncol Clin North Am , vol.7 , pp. 389-400
    • Tucker, M.A.1
  • 53
    • 0028154066 scopus 로고
    • Second cancer risk following Hodgkin's disease: A twenty year follow-up study
    • van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A twenty year follow-up study. J Clin Oncol 12:312-325, 1994.
    • (1994) J Clin Oncol , vol.12 , pp. 312-325
    • Van Leeuwen, F.E.1    Klokman, W.J.2    Hagenbeek, A.3
  • 54
    • 0025757319 scopus 로고
    • Impact of adjuvant radiation on the patterns and rate of relapse in advanced stage Hodgkin's disease treated with alternating chemotherapy combinations
    • Yahalom J, Ryu J, Straus DJ, et al: Impact of adjuvant radiation on the patterns and rate of relapse in advanced stage Hodgkin's disease treated with alternating chemotherapy combinations. J Clin Oncol 9:2193-2201, 1991.
    • (1991) J Clin Oncol , vol.9 , pp. 2193-2201
    • Yahalom, J.1    Ryu, J.2    Straus, D.J.3
  • 55
    • 0022613464 scopus 로고
    • Second neoplasms in patients with Hodgkin's disease following combined modality therapy: The Yale experience
    • Koletsky AJ, Bertino JR, Farber LR, et al: Second neoplasms in patients with Hodgkin's disease following combined modality therapy: The Yale experience. J Clin Oncol 4:311-317, 1986.
    • (1986) J Clin Oncol , vol.4 , pp. 311-317
    • Koletsky, A.J.1    Bertino, J.R.2    Farber, L.R.3
  • 56
    • 0028923241 scopus 로고
    • Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease
    • Beaty O, Hudson MM, Greenwald C, et al: Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609, 1995.
    • (1995) J Clin Oncol , vol.13 , pp. 603-609
    • Beaty, O.1    Hudson, M.M.2    Greenwald, C.3
  • 57
    • 0025883101 scopus 로고
    • Therapeutic radiation at a young age is linked to secondary thyroid cancer
    • Tucker MA, Morris J, Boyce JD, et al: Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 51:2885-2888, 1991.
    • (1991) Cancer Res , vol.51 , pp. 2885-2888
    • Tucker, M.A.1    Morris, J.2    Boyce, J.D.3
  • 58
    • 0029101448 scopus 로고
    • Second solid malignancies after combined modality therapy for Hodgkin's disease
    • Doria R, Holford T, Farber LR, et al: Second solid malignancies after combined modality therapy for Hodgkin's disease. J Clin Oncol 13:2016-2022, 1995.
    • (1995) J Clin Oncol , vol.13 , pp. 2016-2022
    • Doria, R.1    Holford, T.2    Farber, L.R.3
  • 59
    • 0027405102 scopus 로고
    • Cellular, molecular and carcinogenic effects of radiation
    • Little JB: Cellular, molecular and carcinogenic effects of radiation. Hematol/Oncol Clin North Am 7:337-352, 1993.
    • (1993) Hematol/Oncol Clin North Am , vol.7 , pp. 337-352
    • Little, J.B.1
  • 60
    • 0023239053 scopus 로고
    • Bone sarcoma linked to radiotherapy and chemotherapy in children
    • Tucker MA, D'angio GJ, Boyce JD, et al: Bone sarcoma linked to radiotherapy and chemotherapy in children. N Engl J Med 317: 588-593, 1987.
    • (1987) N Engl J Med , vol.317 , pp. 588-593
    • Tucker, M.A.1    D'Angio, G.J.2    Boyce, J.D.3
  • 62
    • 0023908059 scopus 로고
    • Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data
    • Prosnitz LR, Farber LR, Kapp DS, et al: Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data. J Clin Oncol 6:603-612, 1988.
    • (1988) J Clin Oncol , vol.6 , pp. 603-612
    • Prosnitz, L.R.1    Farber, L.R.2    Kapp, D.S.3
  • 63
    • 0028322068 scopus 로고
    • Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group Randomized study
    • Fabian CJ, Mansfield CM, Dahlberg S, et al: Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group Randomized study. Ann Intern Med 120:903-912, 1994.
    • (1994) Ann Intern Med , vol.120 , pp. 903-912
    • Fabian, C.J.1    Mansfield, C.M.2    Dahlberg, S.3
  • 64
    • 0023898728 scopus 로고
    • The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease
    • Radford JA, Cowan RA, Flanagan M, et al: The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol 6:940-946, 1988.
    • (1988) J Clin Oncol , vol.6 , pp. 940-946
    • Radford, J.A.1    Cowan, R.A.2    Flanagan, M.3
  • 65
    • 0021966516 scopus 로고
    • The significance of the residual mediastinal mass in treated Hodgkin's disease
    • Jochelson M, Mauch P, Balikian J, et al: The significance of the residual mediastinal mass in treated Hodgkin's disease. J Clin Oncol 3:637-640, 1985.
    • (1985) J Clin Oncol , vol.3 , pp. 637-640
    • Jochelson, M.1    Mauch, P.2    Balikian, J.3
  • 66
    • 0027315201 scopus 로고
    • Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy
    • Cooper DL, Caride VJ, Zloty M, et al: Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy. J Clin Oncol 11:1092-1098, 1993.
    • (1993) J Clin Oncol , vol.11 , pp. 1092-1098
    • Cooper, D.L.1    Caride, V.J.2    Zloty, M.3
  • 67
    • 0028012497 scopus 로고
    • Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease
    • King SC, Reiman RJ, Prosnitz LR: Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease. J Clin Oncol 12:306-311, 1994.
    • (1994) J Clin Oncol , vol.12 , pp. 306-311
    • King, S.C.1    Reiman, R.J.2    Prosnitz, L.R.3
  • 68
    • 0028923512 scopus 로고
    • Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake
    • Even-Sapir E, Bar-Shalom R, Israel O, et al: Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake. J Clin Oncol 13:942-946, 1995.
    • (1995) J Clin Oncol , vol.13 , pp. 942-946
    • Even-Sapir, E.1    Bar-Shalom, R.2    Israel, O.3
  • 69
    • 0022553175 scopus 로고
    • Twenty years of MOPP therapy for Hodgkin's disease
    • Longo, DL, Young RC, Wesley M, et al: Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 4:1295-1306, 1986.
    • (1986) J Clin Oncol , vol.4 , pp. 1295-1306
    • Longo, D.L.1    Young, R.C.2    Wesley, M.3
  • 70
    • 0021075273 scopus 로고
    • A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy
    • Carde P, MacKintosh FR, Rosenberg SA: A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy. J Clin Oncol 1:146-153, 1983.
    • (1983) J Clin Oncol , vol.1 , pp. 146-153
    • Carde, P.1    MacKintosh, F.R.2    Rosenberg, S.A.3
  • 71
    • 0025796905 scopus 로고
    • British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease
    • Hancock BW, Vaughan Hudson G, Vaughan Hudson B, et al: British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. Br J Cancer 63:579-582, 1991.
    • (1991) Br J Cancer , vol.63 , pp. 579-582
    • Hancock, B.W.1    Vaughan Hudson, G.2    Vaughan Hudson, B.3
  • 72
    • 0023689707 scopus 로고
    • Prognostic factors for survival in stage IIIB and IV Hodgkin's disease
    • Wagstaff J, Gregory WM, Swindell R, et al: Prognostic factors for survival in stage IIIB and IV Hodgkin's disease. Br J Cancer 58:487-492, 1988.
    • (1988) Br J Cancer , vol.58 , pp. 487-492
    • Wagstaff, J.1    Gregory, W.M.2    Swindell, R.3
  • 73
    • 0026576748 scopus 로고
    • Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years
    • Oza AM, Ganesan TS, Dorreen M, et al: Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years. Br J Cancer 65:429-437, 1992.
    • (1992) Br J Cancer , vol.65 , pp. 429-437
    • Oza, A.M.1    Ganesan, T.S.2    Dorreen, M.3
  • 74
    • 0026558004 scopus 로고
    • Combined chemotherapy and radiotherapy for Hodgkin's disease
    • Prosnitz LR, Roberts KB: Combined chemotherapy and radiotherapy for Hodgkin's disease. Oncology 6:113-128, 1992.
    • (1992) Oncology , vol.6 , pp. 113-128
    • Prosnitz, L.R.1    Roberts, K.B.2
  • 75
    • 0026751950 scopus 로고
    • Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV a and B Hodgkin's disease
    • Pavlovsky S, Santarelli MT, Sackmann MF, et al: Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A and B Hodgkin's disease. Ann Oncol 3:533-537, 1992.
    • (1992) Ann Oncol , vol.3 , pp. 533-537
    • Pavlovsky, S.1    Santarelli, M.T.2    Sackmann, M.F.3
  • 76
    • 0021201893 scopus 로고
    • A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged HIA Hodgkin's disease
    • Crowther D, Wagstaff J, Deakin D, et al: A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged HIA Hodgkin's disease. J Clin Oncol 2:892-897, 1984.
    • (1984) J Clin Oncol , vol.2 , pp. 892-897
    • Crowther, D.1    Wagstaff, J.2    Deakin, D.3
  • 77
    • 0022005980 scopus 로고
    • The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984
    • Rosenberg SA, Kaplan HS: The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984. Int J Radiat Oncol Biol Phys 11:5-22, 1985.
    • (1985) Int J Radiat Oncol Biol Phys , vol.11 , pp. 5-22
    • Rosenberg, S.A.1    Kaplan, H.S.2
  • 78
    • 0026094294 scopus 로고
    • Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial
    • Yelle L, Bergsagel D, Basco V, et al: Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial. J Clin Oncol 9:1983-1993, 1991.
    • (1991) J Clin Oncol , vol.9 , pp. 1983-1993
    • Yelle, L.1    Bergsagel, D.2    Basco, V.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.